文献速递医学人工智能与信息学临床试验与 GCP流行病学与生物统计

基于人工智能与机器学习的策略提升随机临床试验的公平性、多样性与包容性

AI/ML-based strategies for enhancing equity, diversity, and inclusion in randomized clinical trials.
PubMed 文献 · Trials · 2026-02-13

本文提出一个概念框架,将公平性、多样性与包容性嵌入临床试验全生命周期。文章指出女性、老年人、种族和族裔少数群体及社会经济弱势群体在随机临床试验中常被代表不足,影响结果外推并可能加剧健康差异。作者提出整合预测建模、适应性试验设计和持续偏倚检测的AI/ML框架,并强调伦理与法律保障。

要点

  • 女性、老年人、种族和族裔少数群体及社会经济弱势群体在随机临床试验中常被代表不足。
  • AI/ML可支持更具包容性的研究设计、针对性招募和试验全程实时多样性监测。
  • 作者提出整合预测建模、适应性设计和持续偏倚检测的AI/ML框架,并强调伦理与法律保障。

核心结论

  • 分析揭示当前随机临床试验中不同人口学群体间存在持续差距,表明亟需系统性干预。
  • 本研究贡献了一个通过预测建模、适应性设计和持续偏倚监测来操作化公平性的AI/ML框架,为研究者提升临床试验科学有效性和伦理完整性提供结构化路径。

研究设计与样本

  • 本文为概念性框架文章,旨在将公平性、多样性与包容性嵌入临床试验全生命周期。

主要发现

  • 随机临床试验仍是评估医学治疗最可靠的方法,但代表性的持续差距削弱其有效性和公平性。
  • 女性、老年人、种族和族裔少数群体及社会经济弱势群体常被代表不足,引发试验结果能否推广至所有患者的担忧。
  • 缺乏包容性不仅限制科学严谨性,还可能强化现有健康差异。
  • AI/ML技术可支持更具包容性的研究设计、针对性招募被代表不足人群,并在试验过程中实时监测多样性。
  • AI/ML还可应用公平感知方法分析结局,帮助确保结果在不同亚组中有意义。

关键数值与推荐

  • 所提框架整合预测建模、适应性试验设计和持续偏倚检测,并配以伦理与法律保障以确保负责任部署。
  • 通过将公平性嵌入试验全生命周期各阶段,该方法为更具体表性和可信的医学证据提供路径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This paper introduces a conceptual framework designed to embed equity, diversity, and inclusion (EDI) across all stages of the clinical trial lifecycle. Randomized clinical trials (RCTs) remain the most reliable method for evaluating medical treatments, yet persistent gaps in representation undermine their validity and fairness. Women, older adults, racial and ethnic minorities, and socioeconomically disadvantaged groups are often underrepresented, raising concerns about whether trial results can be generalized to all patients. This lack of inclusivity not only limits scientific rigor but also risks reinforcing existing health disparities. Recent advances in artificial intelligence (AI) and machine learning (ML) provide new opportunities to address these challenges. These technologies can support more inclusive study designs, enable targeted recruitment of underrepresented populations, and monitor diversity in real time throughout the trial process. They can also be applied to analyze outcomes with fairness-aware methods, helping ensure that results are meaningful across diverse subgroups. In this work, we propose an AI/ML-based framework aimed at operationalizing equity, diversity, and inclusion in clinical research. The framework integrates predictive modeling, adaptive trial designs, and continuous bias detection with ethical and legal safeguards to ensure responsible deployment. By embedding fairness into every stage of the trial lifecycle, this approach offers a pathway toward more representative and trustworthy evidence in medical science. Our analysis reveals the persistent gaps across demographic groups in current RCTs, demonstrating the urgent requirement for systematic intervention. This study also contributes a comprehensive AI/ML framework that operationalizes equity through predictive modeling, adaptive designs, and continuous bias monitoring, providing a structured pathway for researchers to enhance both the scientific validity and ethical integrity of clinical trials.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Abbidi SR, Sinha D. AI/ML-based strategies for enhancing equity, diversity, and inclusion in randomized clinical trials. Trials. 2026. PMID: 41680855. doi:10.1186/s13063-026-09537-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。